The management restructuring, including the reduction of management layers, will accelerate savings under the company's Invigorate cost-reduction initiative, and is expected to add between $15 million and $20 million to the previously disclosed charges.
Quest Diagnostics is the world's leading provider of diagnostic testing, information and services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic testing services through its network of laboratories and patient service centers, and provides interpretive consultation through its extensive medical and scientific staff. Quest Diagnostics is a pioneer in developing innovative diagnostic tests and advanced healthcare information technology solutions that help improve patient care. Additional company information is available at: www.QuestDiagnostics.com.
Contacts: Kathleen Valentine (Investors), +1-973-520-2900; Wendy Bost (Media), +1-973-520-2800
SOURCE Quest Diagnostics Incorporated